Chiron Dealt Blow Over Cystic Fibrosis Treatment
In a setback for biopharmaceutical company Chiron Corp., a federal judge has ruled that the company's medical-method patent covering a drug-device combination used by cystic fibrosis victims cannot be used to...To view the full article, register now.
Already a subscriber? Click here to view full article